II. Organ-specific effects of systemic inflammatory activation: T lymphocytes in asthma: Bronchial versus peripheral responses

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 5 SUPPL., 2000, Pages

  Durham, Stephen R ^a   Till, Stephen J ^a   Corrigan, Christopher J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Bronchial asthma; Cytokines; In situ hybridization

Indexed keywords

ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; BRONCHUS REACTIVITY; EOSINOPHILIA; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; BLOOD; BRONCHUS; IMMUNOLOGY; METABOLISM; MUCOSA; PATHOLOGY; PHENOTYPE; SECRETION; TH1 CELL; TH2 CELL;

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMALS; ASTHMA; BRONCHI; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MUCOUS MEMBRANE; PHENOTYPE; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0033696425     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.110154     Document Type: Review

References (43)

1. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins
2. + T lymphocytes in atopic patients
3. The role of lymphocytes in allergic disease
4. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants
5. The role of IL-13 and its receptor in allergy and inflammatory responses
6. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF
7. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium
8. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones
9. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type
10. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses
11. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia
12. Predominant T(H)2-like bronchoalveolar T-lymphocyte population in atopic asthma
13. T lymphocyte activation in acute severe asthma
14. CD4 T-lymphocyte activation in acute severe asthma: Relationship to disease severity and atopic status
15. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy
16. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: Effect of glucocorticoid therapy
17. + T cells in primary culture: Relationship to expression of allergic disease
18. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
19. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: Relation to asthma symptoms, lung function, and bronchial responsiveness
20. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma
21. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: Relationship to symptoms and bronchial responsiveness
22. Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma
23. + T cells, increased T(H)2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
24. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin,5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
25. Late allergic responses
26. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
27. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferongamma cytokine gene expression
28. + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis
29. Allergen immunotherapy: Therapeutic vaccines for allergic diseases: Geneva: January 27-29, 1997
30. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens
31. Changes in nasal metachromatic cells during allergen immunotherapy
32. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy
33. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity
34. Immunologic changes associated with allergen immunotherapy
35. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
36. + cells accompany inhibition of allergen-induced late skin responses following successful grass pollen immunotherapy
37. Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge
38. T cells from human allergen-inducec late asthmatic responses express IL-12 receptor beta 2 subunit mRNA and respond to IL-12 in vitro
39. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
40. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma
41. Effects of an antibody to interleukin-5 in a monkey model of asthma
42. Mechanism of extended duration of anti-IL-5 antibodies against pulmonary eosinophilia [abstract]
43. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial